# Biocon already uses models like Oracle, Microsoft Co-pilot and OpenAI for operational uses.

*fintech · news · 2026-04-08 · Livemint*

## Key points

- Anthropic launched a dedicated life sciences business division in October last year.
- Biocon uses generative AI models for procurement to compare vendors and reduce input costs.
- Peptris Technologies developed India's first AI-discovered drug candidate, licensed to Revio Therapeutics in March 2025.
- Indian biotech firms face challenges in acquiring AI talent or must pursue M&A for AI-led drug discovery.

**Companies:** Biocon, Anthropic, Oracle, Microsoft, OpenAI, Alphafold, Peptris Technologies, Revio Therapeutics
**Countries:** India

[Read the full story on Livemint](https://www.livemint.com/technology/india-pharma-ai-anthropic-coefficient-bio-drug-discovery-sun-pharma-biocon-glenmark-11775418665231.html)

---

Canonical: https://newsio.io/n/2a47865d-7475-457f-94b3-acb49fea7ac1/biocon-already-uses-models-like-oracle-microsoft-co-pilot-and-openai-for-operati
Summarized by Newsio from Livemint. https://newsio.io/how-it-works